Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Dupixent (Dupilumab).
Allergic reactions: Some people may develop an allergic reaction to Dupixent (Dupilumab). Signs of an allergic reaction include a severe rash, hives, swollen face or throat, or difficulty breathing. If these occur, contact your doctor immediately.
Another form of allergic reaction that can happen, although rarely, is serum sickness. Symptoms of serum sickness include fever, feeling unwell, swollen lymph nodes, hives, joint pain, skin rash, or itchiness.
If you have symptoms of either type of allergic reaction, contact your doctor immediately.
Eye problems: Inflammation of the cornea of the eye and the white part of the eye have been reported by people using Dupixent (Dupilumab). If you experience symptoms such as red eyes, moderate-to-severe eye pain, a feeling of grittiness in the eye, or increased sensitivity to light, contact your doctor as soon as possible.
Parasite infections: Dupixent (Dupilumab) may weaken your resistance to parasite infections. If you already have a parasite infection it should be treated before starting Dupixent (Dupilumab). If you are living in or travelling to a region where parasite infections are frequent, discuss with your doctor any special precautions that may be needed.
Vaccines: Live vaccines (e.g., yellow fever, BCG, Cholera, typhoid, varicella) should not be given when you are taking Dupixent (Dupilumab).
Pregnancy: Dupixent (Dupilumab) should not be used during pregnancy unless the benefits outweigh the risks. If you become pregnant while taking Dupixent (Dupilumab), contact your doctor immediately.
Breast-feeding: It is not known if Dupixent (Dupilumab) passes into breast milk. If you are a breast-feeding mother and are taking Dupixent (Dupilumab), it may affect your baby. Talk to your doctor about whether you should continue breast-feeding.
Children: The safety and effectiveness of using Dupixent (Dupilumab) have not been established for children under the age of 12 years.